| Infection* |
Cipro® TabletsA |
Cipro Oral SuspensionA,B,C |
Cipro I.V.D |
|
Uncomplicated UTIs -acute uncomplicated
-mild/moderate |
250 mg bid for 3 days |
5%5 mL q12h 10%2.5 mL q12h for 3 days |
|
| 250 mg bid for 7 to 14 days |
5%5 mL q12h 10%2.5 mL q12h for 7 to 14 days |
200 mg q12h |
Complicated UTIs -severe/complicated |
500 mg bid for 7 to 14 days |
5%10 mL q12h 10%5 mL q12h for 7 to 14 days |
400 mg q12h |
Chronic bacterial prostatitis -mild/moderate |
500 mg bid for 28 days |
5%10 mL q12h 10%5 mL q12h for 28 days |
400 mg q12h |
Urethral and cervical gonococcal infections -uncomplicated |
250 mg single dose |
5%5 mL 10%2.5 mL single dose
|
|
|
Acute sinusitis -mild/moderate |
500 mg bid for 10 days |
5%10 mL q12h 10%5 mL q12h for 10 days |
400 mg q12h |
Lower respiratory tract; Skin and skin structure -mild/moderate
-severe/complicated |
500 mg bid for 7 to 14 days
|
5%10 mL q12h 10%5 mL q12h for 7 to 14 days |
400 mg q12h |
| 750 mg bid for 7 to 14 days |
5%15 mL q12h 10%7.5 mL q12h for 7 to 14 days |
400 mg q8h |
Bone and joint -mild/moderate
-severe/complicated |
500 mg bid for >4 to 6 weeks |
5%10 mL q12h 10%5 mL q12h for >4 to 6 weeks |
400 mg q12h |
| 750 mg bid for >4 to 6 weeks |
5%15 mL q12h 10%7.5 mL q12h for >4 to 6 weeks |
400 mg q8h |
Intra-abdominal (in combination with metronidazole) -complicated |
500 mg bid for 7 to 14 days |
5%10 mL q12h 10%5 mL q12h for 7 to 14 days |
400 mg q12h |
Infectious diarrhea -mild/moderate/severe |
500 mg bid for 5 to 7 days |
5%10 mL q12h 10%5 mL q12h for 5 to 7 days |
|
Inhalational anthraxE (post-exposure) |
Adults: 500 mg bid for 60 days
ChildrenF: 15 mg/kg bid not to exceed 500 mg per dose for 60 days |
Adults: 5%10 mL q12h 10%5 mL q12h for 60 days
ChildrenF: 15 mg/kg bid not to exceed 500 mg per dose for 60 days |
Adults: 400 mg q12h
ChildrenF: 10 mg/kg q12h not to exceed 400 mg per dose |